Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland

被引:0
|
作者
Radecka, B. [1 ]
Gelej, M. [2 ]
Streb, J. [3 ]
Siedlaczek, A. [4 ]
Kryka, K. [3 ]
Tokajuk, P. [5 ]
Winsko-Szczesnowicz, K. [5 ]
Czernek, U. [6 ]
Sobczak, M. [7 ]
Malik, M. [8 ]
Bodnar, L. [9 ]
Foszczynska-Kloda, M. [10 ]
Hetman, K. [10 ]
Skiewicz, M. Welnicka-Ja [11 ]
Wierzbicka, K. [11 ]
Orlikowska, M. [12 ]
Becht, R. [13 ]
Deptala, A. [14 ]
Itrych, B. [15 ]
Kania-Zembaczynska, B. [16 ]
机构
[1] Univ Opole, Inst Med Sci, Dept Oncol, Opole, Poland
[2] Tadeusz Koszarowski Reg Canc Ctr, Dept Clin Oncol, Opole, Poland
[3] Jagiellonian Univ Hosp Krakow, Krakow, Poland
[4] Univ Opole, Inst Math & Comp Sci, Opole, Poland
[5] Comprehens Canc Ctr Bialystok, Med Oncol Dept, Bialystok, Poland
[6] Med Univ Lodz, Copernicus Mem Hosp Lodz, Dept Chemotherapy, Lodz, Poland
[7] Copernicus Mem Hosp Lodz, Lodz, Poland
[8] Lower Silesian Oncol Ctr, Clin Oncol Dept, Wroclaw, Poland
[9] Warmia & Mazury Oncol Ctr, MSWiA Hosp, Oncol & Immunooncol Clin, Olsztyn, Poland
[10] West Pomeranian Oncol Ctr Szczecin, Szczecin, Poland
[11] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland
[12] Kociewie Hlth Ctr Starogard Gdanski, Oncol Dept, Starogard Gdanski, Poland
[13] Pomeranian Med Univ, Clin Dept Oncol Chemotherapy & Canc Immunotherapy, Szczecin, Poland
[14] Med Univ Warsaw, Cent Clin Hosp MSWiA, Clin Oncol & Hematol, Warsaw, Poland
[15] Cent Clin Hosp MSWiA, Clin Oncol & Breast Dis, Ctr Postgrad Med Educ, Warsaw, Poland
[16] Beskidian Oncol Ctr Bielsko Biala, Dept Oncol & Oncohematol, Bielsko Biala, Poland
关键词
D O I
10.1016/j.annonc.2020.04.139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-57
引用
收藏
页码:S108 / S108
页数:1
相关论文
共 50 条
  • [1] Effectiveness, safety, and prognostic factors of trifluridine/tipiracil for the treatment of patients with metastatic colorectal cancer in routine clinical practice
    Martinez-Perez, Julia
    Espinosa-Montano, Marta
    Luque-Caro, Natalia
    Avino-Tarazona, Victoria
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (02) : 692 - +
  • [2] A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice
    Borelli, Beatrice
    Zucchelli, Gemma
    Rossini, Daniele
    Cremolini, Chiara
    Antoniotti, Carlotta
    Moretto, Roberto
    Marmorino, Federica
    Colombo, Camilla
    Vannini, Francesca
    Delliponti, Laura
    Spione, Mario
    Ongaro, Elena
    Masi, Gianluca
    Brunetti, Isa Maura
    Pfanner, Elisabetta
    Salvatore, Lisa
    Falcone, Alfredo
    COLORECTAL CANCER, 2018, 7 (01)
  • [3] The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer
    Martinez-Perez, Julia
    Carmen Riesco-Martinez, M.
    Garcia-Carbonero, Rocio
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (06) : 643 - 650
  • [4] Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution
    Kotani, Daisuke
    Shitara, Kohei
    Kawazoe, Akihito
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    CLINICAL COLORECTAL CANCER, 2016, 15 (03) : E109 - E115
  • [5] Safety and efficacy of trifluridine/tipiracil monotherapy in metastatic colorectal cancer
    Aparicio Rubio, C.
    Monteagudo Santolaya, E.
    Cornejo Uixeda, S.
    Prieto Castello, M.
    Antonino de la Camara, G.
    Quintana Vergara, B.
    Sanchez Alcaraz, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 373 - 374
  • [6] Safety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal cancer
    Kotani, D.
    Kuboki, Y.
    Yasuda, K.
    Nakamura, Y.
    Kawazoe, A.
    Bando, H.
    Taniguchi, H.
    Shitara, K.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 34 - 34
  • [7] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Yoshiaki Fujimoto
    Ryota Nakanishi
    Mamoru Nukatsuka
    Kazuaki Matsuoka
    Koji Ando
    Takeshi Wakasa
    Hiroyuki Kitao
    Eiji Oki
    Yoshihiko Maehara
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038
  • [8] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Fujimoto, Yoshiaki
    Nakanishi, Ryota
    Nukatsuka, Mamoru
    Matsuoka, Kazuaki
    Ando, Koji
    Wakasa, Takeshi
    Kitao, Hiroyuki
    Oki, Eiji
    Maehara, Yoshihiko
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1029 - 1038
  • [9] Safety of trifluridine/tipiracil (FTD/TPI) in elderly patients with metastatic colorectal cancer.
    Mayer, Robert J.
    Hochster, Howard S.
    Cohen, Steven J.
    Winkler, Robert
    Makris, Lukas
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Celeste B. Burness
    Sean T. Duggan
    Drugs, 2016, 76 : 1393 - 1402